La carga de enfermedad renal crónica en México. Análisis de datos basado en el estudio <i>Global Burden of Disease</i> 2021
Eduardo R. Argaiz(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Gerardo Gamba(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Linda Morales‐Juárez(Tecnológico de Monterrey), Christian Razo(University of Washington), Rodolfo Rincón-Pedrero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Quinn Rafferty(Institute for Health Metrics and Evaluation), Liane Ong(Tecnológico de Monterrey)
Cited by 12
Related Papers
Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|1.7k
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|541
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
|The Lancet Global Health|2025|72
The Swiss Brain Health Plan 2023–2033
|Clinical and Translational Neuroscience|2023|39
Estimating global direct health-care spending on neurological and mental health between 2000 and 2019: a modelling study
|The Lancet Public Health|2025|15